Signal transduction inhibitors, compositions containing them
申请人:Ariad Pharmaceuticals, Inc.
公开号:US06576766B1
公开(公告)日:2003-06-10
This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediate by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to pharmaceutic compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds. The compounds are of formula (1) as defined herein.